These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21728320)

  • 1. Galacto-configured aminocyclitol phytoceramides are potent in vivo invariant natural killer T cell stimulators.
    Harrak Y; Barra CM; Delgado A; Castaño AR; Llebaria A
    J Am Chem Soc; 2011 Aug; 133(31):12079-84. PubMed ID: 21728320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
    Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
    J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
    Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
    Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).
    Shiozaki M; Tashiro T; Koshino H; Nakagawa R; Inoue S; Shigeura T; Watarai H; Taniguchi M; Mori K
    Carbohydr Res; 2010 Aug; 345(12):1663-84. PubMed ID: 20591421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
    Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
    Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective stimulation of invariant natural killer T cells by oligomannose-coated liposomes.
    Ishii M; Kojima N
    Int Immunopharmacol; 2013 Apr; 15(4):685-92. PubMed ID: 23535021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminocyclitol-substituted phytoceramides and their effects on iNKT cell stimulation.
    Harrak Y; Barra CM; Bedia C; Delgado A; Castaño AR; Llebaria A
    ChemMedChem; 2009 Oct; 4(10):1608-13. PubMed ID: 19739197
    [No Abstract]   [Full Text] [Related]  

  • 9. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
    Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
    J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.
    Kerzerho J; Yu ED; Barra CM; Alari-Pahissa E; Girardi E; Harrak Y; Lauzurica P; Llebaria A; Zajonc DM; Akbari O; Castaño AR
    J Immunol; 2012 Mar; 188(5):2254-65. PubMed ID: 22301545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
    Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
    Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient synthesis of galactosylceramide analogues for iNKT cell stimulation.
    Chen W; Xia C; Cai L; Wang PG
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3859-62. PubMed ID: 20627566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells.
    Lu X; Song L; Metelitsa LS; Bittman R
    Chembiochem; 2006 Nov; 7(11):1750-6. PubMed ID: 17009272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide).
    Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
    Carbohydr Res; 2013 Apr; 370():46-66. PubMed ID: 23454137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
    Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
    Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide.
    Bontkes HJ; Moreno M; Hangalapura B; Lindenberg JJ; de Groot J; Lougheed S; van der Vliet HJ; van den Eertwegh AJ; de Gruijl TD; von Blomberg BM; Scheper RJ
    Clin Immunol; 2010 Sep; 136(3):364-74. PubMed ID: 20570567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
    Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
    Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
    Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.